2019冠状病毒病(COVID-19)患者的延迟期血小板减少症
这项回顾性单中心研究筛查了2020年1月25日至3月9日武汉协和医院450例COVID-19患者并纳入271例,发现11.8%出现COVID-19相关延迟期血小板减少(症状出现14天后发生),多见于高龄或入院时淋巴细胞计数低的患者,与住院时间延长和死亡率升高显著相关。
要点
- COVID-19相关延迟期血小板减少发生于11.8%的纳入患者。
- 高龄或入院时淋巴细胞计数低的患者易发生延迟期血小板减少。
- 延迟期血小板减少与住院时间延长和死亡率升高显著相关。
核心结论
- COVID-19相关延迟期血小板减少发生于11.8%的纳入患者,与住院时间延长和死亡率升高显著相关,临床医生需关注症状出现后3-4周的延迟期血小板减少。
研究设计与样本
- 回顾性单中心研究,筛查450例COVID-19患者,纳入271例,地点为武汉协和医院,时间为2020年1月25日至3月9日。
主要发现
- COVID-19相关延迟期血小板减少发生于11.8%的纳入患者。
- 延迟期血小板减少易发生于高龄患者或入院时淋巴细胞计数低的患者。
- 延迟期血小板减少与住院时间延长和死亡率升高显著相关。
- 延迟期血小板最低值与B细胞百分比呈显著负相关。
- 3例延迟期血小板减少患者的骨髓穿刺病理显示巨核细胞成熟受损。
临床怎么用
- 作者推测免疫介导的血小板破坏可能解释部分患者的延迟期血小板减少。
- 作者指出临床医生需关注延迟期血小板减少,尤其是症状出现后3-4周。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) can affect the haematopoietic system. Thrombocytopenia at admission was prevalent, while late-phase or delayed-phase thrombocytopenia (occurred 14 days after symptom onset) is rare. This retrospective, single-centre study screened 450 COVID-19 patients and enrolled 271 patients at the Union Hospital, Wuhan, China, from January 25 to March 9, 2020. COVID-19-associated delayed-phase thrombocytopenia occurred in 11·8% of enrolling patients. The delayed-phase thrombocytopenia in COVID-19 is prone to develop in elderly patients or patients with low lymphocyte count on admission. The delayed-phase thrombocytopenia is significantly associated with increased length of hospital stay and higher mortality rate. Delayed-phase nadir platelet counts demonstrated a significantly negative correlation with B cell percentages. We also provided and described bone marrow aspiration pathology of three patients with delayed-phase thrombocytopenia, showing impaired maturation of megakaryocytes. We speculated that immune-mediated platelet destruction might account for the delayed-phase thrombocytopenia in a group of patients. In addition, clinicians need to pay attention to the delayed-phase thrombocytopenia especially at 3-4 weeks after symptom onset.
引用
- Chen W, Li Z, Yang B, et al. Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19). Br J Haematol. 2020. PMID: 32453877. doi:10.1111/bjh.16885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。